SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (2687)7/27/2010 5:14:11 PM
From: DewDiligence_on_SI1 Recommendation  Read Replies (1) of 3661
 
Assuming for the sake of discussion that your thesis about Brilinta is correct, wouldn’t the FDA’s somewhat skeptical briefing docs for Brilinta be construed by investors as bullish for Lovenox and MNTA by downgrading the threat from a potential competitor? I just don’t see how the Brilinta briefing docs could be bearish for MNTA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News